Análise das conciliações de medicamentos realizadas por um serviço de farmácia clínica de um hospital universitário

Abstract

Despite limited access to medicines, the substantial increase in use associated with medication errors, especially in the hospital context, poses risks to the patient and raises costs in health systems. In this context, medication reconciliation becomes a useful service to minimize and / or avoid these errors. However, there are few Brazilian studies that analyze the impact of medication reconciliation on the occurrence of medication errors, as well as on patient safety. Thus, the present study aims to analyze the reconciliations medications carried out in medical clinic units of the University Hospital Walter Cantídio from January to December 2019. This is a retrospective quantitative cross-sectional study, of the documentary type. The drugs were classified according to the ATC code (Anatomical Therapeutic Classification), and the analysis was done in Excel®. Among the reconciliations carried out (n = 280), most were carried out with male patients (n= 158; 56.43%), with an average age of 57 years. Hypertension, diabetes and dyslipidemia were the main comorbidities presented. Most patients were reconciled belonging to cardiology (n= 153; 55%) and held polypharmacy (n= 108; 42.19%). It is noteworthy that a significant proportion of patients (n=157; 61.33%) had at least one discrepancy between the drugs in use, especially those drugs that act on the alimentary tract and metabolism (n=120; 36.4%), cardiovascular system (n= 82; 24.8%), blood and blood-forming organs (n= 36; 10.9%). Most reconciliations were made within 24 hours (n=168; 60%), as recommended. Finally, the data presented it possible to trace the profile of patients reconciled, identify risk groups for discrepancies to make the reconciliation medication service more effective contributing to a safe patient therapy